Please assess the completion status of the following clinical trial:

Trial Title: Whole Brain Radiotherapy (WBRT) Versus Stereotactic Radiosurgery (SRS) for 4 Upto 10 Brain Metastases

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Minimal 4 up to a maximum of 10 BM on diagnostic MRI scan~* Max diameter of single GTV 2.5cm~* Max cumulative GTV of 30cm3~* Karnofsky performance status ≥ 70~* Any solid primary tumour. Small cell lung carcinoma, germinoma, and lymphoma are excluded~* Ability to provide written informed consent~Exclusion Criteria:~* Contra-indication for MRI~* Prior treatment for BM (i.e. surgery, SRS or WBRT)~* Concurrent use of systemic therapy~* Maximum cumulative GTV of more than 30cm3 on planning-MRI~* More than 10 BM on planning-MRI~* A brainstem metastasis with a PTV of more than 20 cm3

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Stereotactic Radiosurgery (Type: EXPERIMENTAL): Stereotactic Radiosurgery for patients with 4 up to 10 brain metastases:
- Whole Brain Radiotherapy (Type: OTHER): Whole Brain Radiotherapy for patients with 4 up to 10 brain metastases:

Based on this trial design, predict the completion outcome and termination type (if applicable).